- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01968564
Oral Curcumin Supplementation in Middle-Aged and Older Adults Improves Vascular Function
March 17, 2017 updated by: University of Colorado, Boulder
Clinical Translation of Curcumin Therapy to Treat Arterial Aging
The proposed study will assess the ability of curcumin, the active ingredient in the Indian spice tumeric, to improve the function of arteries with age.
Overall, the proposed research project has the long-term potential to influence clinical practice guidelines by establishing a novel, easy to deliver, cost-effective therapy for treating age-associated arterial dysfunction and reducing the risk of cardiovascular disease with age.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
118
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Boulder, Colorado, United States, 80309
- University of Colorado Boulder, Clinical Translational Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- women must be postmenopausal
- body mass index (BMI) <40 kg/m2
- weight stable in the prior 3 months
- absence of clinical disease as determined by medical history, physical examination, blood and urine chemistries, ankle-brachial index, and a graded exercise stress test with monitoring of blood pressure and 12-lead ECG
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo pill
|
sugar and other inert substances
|
Experimental: High-dose curcumin pill
|
2000mg curcumin pill/day
|
Experimental: Low-dose curcumin pill
|
500mg curcumin pill/day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Arterial Stiffness
Time Frame: 12 weeks
|
Arterial pulse wave velocity
|
12 weeks
|
Nitric-oxide mediated endothelium-dependent dilation
Time Frame: 12 weeks
|
flow-mediated dilation and forearm blood flow responses to acetylcholine in the presence and absence of N'-monomethyl-L-arginine
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Systemic oxidative stress and inflammation
Time Frame: 12 weeks
|
circulating markers of oxidative stress and inflammation
|
12 weeks
|
Endothelial cell oxidative stress and inflammation
Time Frame: 12 weeks
|
inflammatory and oxidative stress markers in biopsied vascular and arterial endothelial cells
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Jessica Santos-Parker, MS, University of Colorado, Boulder
- Principal Investigator: Douglas Seals, PhD, University of Colorado, Boulder
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Anticipated)
June 1, 2017
Study Completion (Anticipated)
June 1, 2017
Study Registration Dates
First Submitted
October 19, 2013
First Submitted That Met QC Criteria
October 19, 2013
First Posted (Estimate)
October 24, 2013
Study Record Updates
Last Update Posted (Actual)
March 20, 2017
Last Update Submitted That Met QC Criteria
March 17, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Antineoplastic Agents
- Curcumin
Other Study ID Numbers
- B6398
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Aging
-
Medical College of WisconsinRecruiting
-
University of Colorado, BoulderCompletedVascular AgingUnited States
-
Cedars-Sinai Medical CenterUniversity of California, San FranciscoCompletedSecondhand Smoking | Vascular AgingUnited States
-
University Hospital, RouenInstitut National de la Santé Et de la Recherche Médicale, FranceUnknownHealthy | Aging | Vascular StiffnessFrance
-
University of IowaCompletedAging | Endothelial Dysfunction | Vascular StiffnessUnited States
-
Medical College of WisconsinPenn State University; University of LouisvilleNot yet recruitingVascular Diseases | Aging | Telomere Shortening
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of LeedsBradford Teaching Hospitals NHS Foundation TrustActive, not recruiting
-
Iowa State UniversityCompletedHypertension | AgingUnited States
Clinical Trials on High-dose curcumin pill
-
Tasly Pharmaceutical Group Co., LtdNot yet recruiting
-
Hong Kong Baptist UniversityCompleted
-
Neurocentria, Inc.CompletedDepression | Cognitive Impairment | Anxiety | Sleep QualityUnited States
-
Beijing Northland Biotech. Co., Ltd.CompletedAcute Myocardial InfarctionChina
-
National Institute of Diabetes and Digestive and...Washington University School of Medicine; University of Alabama at Birmingham; Icahn School of Medicine at Mount Sinai and other collaboratorsCompletedEnd Stage Renal DiseaseUnited States
-
MedImmune LLCCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
Beijing Northland Biotech. Co., Ltd.CompletedSafety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.InfarctionAcute Myocardial InfarctionChina
-
University of Mary Hardin-BaylorIndus Biotech Ltd. Pvt.CompletedInflammation | Muscle DamageUnited States
-
Baylor College of MedicineNeuroMetrix, Inc.RecruitingPain | Neuropathy | Chemotherapy-induced Peripheral NeuropathyUnited States
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...RecruitingSystemic Lupus ErythematosusUnited States, Spain, China, Korea, Republic of, Argentina, Bulgaria, Chile, Greece, Japan, Mauritius, Mexico, Moldova, Republic of, Poland, South Africa, Australia, Colombia, Philippines, Serbia